Kyowa Kirin Co Ltd banner

Intrinsic Value

The intrinsic value of Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.65 EUR per share. Compared with the current market price of 14.3 EUR, the stock appears Undervalued by 9% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

KY4 Intrinsic Value
€15.65
Undervaluation 9%
Intrinsic Value
Price €14.3
Alert me when KY4 is below its intrinsic value
Today €12.52 · 12.5% below the current price

KY4 is cheaper than usual. It was this cheap or cheaper on just 19% of days in the past 5 years.

Alternatives to KY4

Fundamental Analysis

What Kyowa Kirin Does

Pharmaceuticals Health Care

Kyowa Kirin is a Japanese pharmaceutical company that develops, makes, and sells prescription medicines. Its main business is creating drugs for serious conditions such as blood disorders, kidney-related diseases, and rare diseases, then bringing those medicines to hospitals and specialists who treat those patients. It also works on research and development, which is the starting point for its future drug pipeline.

Headquarters
Japan JP
Employees
5 161
IPO date
Aug 22, 1949
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue KY4 Research

Decided on Kyowa Kirin? Get an email when KY4 reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one KY4 stock?

The intrinsic value for Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.65 EUR.

Is KY4 stock undervalued or overvalued?

Compared with the current market price of 14.3 EUR, the stock appears Undervalued by 9% .

How reliable are our estimates? See how past valuations played out
Back to Top